First versus second year respiratory syncytial virus prophylaxis in chronic lung disease (2005–2015)
Crossref DOI link: https://doi.org/10.1007/s00431-017-2849-4
Published Online: 2017-01-20
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Daniel Y.
,
Li, Abby
Paes, Bosco
Mitchell, Ian
Lanctôt, Krista L.
Funding for this research was provided by:
AbbVie Corporation
License valid from 2017-01-20